CC12CCC(C(=O)NNc3ccc([N+](=O)[O-])cc3)(OC1=O)C2(C)C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?